In Europe, melanoma is the fifth most common type of cancer and is the major cause of death from skin cancer. Northern Europe displays the largest age-standardized rate mortality of 3.8 per 10,000 in the region, with an incidence ...
Nov 9, 2020
0
5
Previous studies have shown that African American men are 2.4 times as likely to die from prostate cancer compared to non-Hispanic white men. This, plus a concern that African Americans may develop cancers that are more aggressive, ...
Nov 3, 2020
0
8
A new drug designed to work on cancers with an altered BRAF gene has shown promise in an early patient trial presented at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, which is taking place ...
Oct 26, 2020
0
2
(HealthDay)—Proper skin care is crucial for cancer patients receiving radiation therapy, the American Academy of Dermatology (AAD) says.
Oct 21, 2020
0
0
Prostate cancer is the most common type of cancer among American men after skin cancer, but the disease does not affect all races equally. African American men are nearly two times more likely to develop prostate cancer, ...
Oct 21, 2020
0
6
QIMR Berghofer research has found almost a quarter of the Queensland population underestimates their risk of developing potentially deadly melanomas—with those at highest risk also the worst at predicting their chances ...
Oct 20, 2020
0
5
Moles stop growing when they reach a certain size due to normal interactions between cells, despite having cancer-associated gene mutations, says a new study published today in eLife.
Oct 13, 2020
0
3
Researchers from the Indian Institute of Science (IISc) have developed a non-invasive bandage made with magnetic nanofibres to treat skin cancer by administering heat to the tumor cells.
Oct 8, 2020
0
5
Capecitabine is a chemotherapy drug used for breast and colorectal cancer. It can extend survival rate by nearly 10%. However, recent studies revealed that almost 50% of patients develop palmar-plantar erythrodysesthesia, ...
Sep 21, 2020
0
2
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
Sep 14, 2020
0
34
